Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...

Healthcare company Baxter International (NYSE:BAX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.3% ...

Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the ...

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025.

A longtime shortage of a type of sterile intravenous saline is now resolved, the Food and Drug Administration announced Friday. According to the FDA, sodium chloride 0.9% injection products ...

Baxter International Inc. closed 30.72% below its 52-week high of $40.49, which the company achieved on September 17th.

Drug and hospital-product manufacturer Baxter International Inc. BAX -2.26% says it has lost “multiple production days” in hurricane-wracked Puerto Rico that will delay its ability to restore ...

The stock's fall snapped a four-day winning streak.